Tandem Diabetes Care TNDM Change in Deferred Revenue
Change in Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's change in deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's change in deferred revenue?
- Tandem Diabetes Care (TNDM) reported change in deferred revenue of -$1.08M in Q1 2026.
- How has Tandem Diabetes Care's change in deferred revenue changed year-over-year?
- Tandem Diabetes Care's change in deferred revenue increased by 32.5% year-over-year, from -$1.6M to -$1.08M.
- What is the long-term trend for Tandem Diabetes Care's change in deferred revenue?
- Over 4 years (2021 to 2025), Tandem Diabetes Care's change in deferred revenue has grown at a -18.0% compound annual growth rate (CAGR), from $10.61M to -$4.79M.
- What does change in deferred revenue mean?
- Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.